These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 7569456)

  • 1. [Tyrosine-protein kinase activity in breast neoplasm. Comparison with activity obtained in benign diseases and in normal tissues].
    Pierart J; Oñate E; Klaassen R; Cid L; Gutierrez S; Talbot E; Ross E; Zambrano C; Burmeister R; Puchi M
    Rev Med Chil; 1995 Feb; 123(2):165-75. PubMed ID: 7569456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tyrosine kinase activity in breast cancer, benign breast disease, and normal breast tissue.
    Hennipman A; van Oirschot BA; Smits J; Rijksen G; Staal GE
    Cancer Res; 1989 Feb; 49(3):516-21. PubMed ID: 2910471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Localization of mineralocorticoid receptor and 11 beta-hydroxysteroid dehydrogenase type II in human breast and its disorders.
    Sasano H; Frost AR; Saitoh R; Matsunaga G; Nagura H; Krozowski ZS; Silverberg SG
    Anticancer Res; 1997; 17(3C):2001-7. PubMed ID: 9216657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative determination of telomerase activity in breast cancer and benign breast diseases.
    Simícková M; Nekulová M; Pecen L; Cernoch M; Vagundová M; Pacovský Z
    Neoplasma; 2001; 48(4):267-73. PubMed ID: 11712677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isozyme patterns of normal, benign, and malignant human breast tissues.
    Balinsky D; Platz CE; Lewis JW
    Cancer Res; 1983 Dec; 43(12 Pt 1):5895-901. PubMed ID: 6640538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Focal adhesion proteins as markers of malignant transformation and prognostic indicators in breast carcinoma.
    Madan R; Smolkin MB; Cocker R; Fayyad R; Oktay MH
    Hum Pathol; 2006 Jan; 37(1):9-15. PubMed ID: 16360410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of the patterns of laminin expression in fibroadenoma, fibrocystic diseases, pre-invasive and invasive ductal breast carcinoma.
    Zheng WQ; Looi LM; Cheah PL
    Pathology; 2001 Aug; 33(3):303-6. PubMed ID: 11523929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic significance of the immunoexpression of CD34 and smooth muscle cell actin in benign and malignant tumors of the breast.
    Cîmpean AM; Raica M; Nariţa D
    Rom J Morphol Embryol; 2005; 46(2):123-9. PubMed ID: 16286998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Carcinoma arising within mammary fibroadenomas. A study of six patients].
    Tissier F; De Roquancourt A; Astier B; Espie M; Clot P; Marty M; Janin A
    Ann Pathol; 2000 Mar; 20(2):110-4. PubMed ID: 10740004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Telomerase activity and its inhibition in benign and malignant breast lesions.
    Sugino T; Yoshida K; Bolodeoku J; Tarin D; Goodison S
    J Pathol; 1997 Sep; 183(1):57-61. PubMed ID: 9370948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Malignant transformation of fibroadenoma of the breast].
    Rohde E
    Zentralbl Gynakol; 1989; 111(24):1629-31. PubMed ID: 2560304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The role of benign tumors and mammary dysplasias in cancerogenesis as related to lysosomal alpha-arylsulfatase and beta-glucoronidase enzyme activity].
    De Sanso G; Bracco G; Tanferna M; Graffino W; Panazzolo A
    Minerva Ginecol; 1981; 33(2-3):185-96. PubMed ID: 6265834
    [No Abstract]   [Full Text] [Related]  

  • 13. C-erbB-2: expression in patients with breast carcinoma in comparison to patients with benign breast diseases.
    Kalogeraki A; Tzardi M; Datseris G; Kanavaros P; Karvelas C; Chalkiadakis G; Tsiftsis D; Delides G
    Anticancer Res; 1996; 16(2):765-71. PubMed ID: 8687126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Semiquantitative cytochemical estimation of glucose-6-phosphate dehydrogenase activity in benign diseases and carcinoma of the breast.
    Bokun R; Bakotin J; Milasinović D
    Acta Cytol; 1987; 31(3):249-52. PubMed ID: 3035846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic value of fine needle aspiration biopsy for breast fibroadenoma diagnosis.
    Szylberg T; Sygut J; Kulig A
    Pol J Pathol; 1997; 48(2):79-86. PubMed ID: 9278103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated content of the tyrosine kinase substrate phospholipase C-gamma 1 in primary human breast carcinomas.
    Arteaga CL; Johnson MD; Todderud G; Coffey RJ; Carpenter G; Page DL
    Proc Natl Acad Sci U S A; 1991 Dec; 88(23):10435-9. PubMed ID: 1683701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of the pattern of cathepsin-D expression in fibroadenoma, fibrocystic disease, preinvasive and invasive ductal breast carcinoma.
    Zheng WQ; Looi LM; Cheah PL
    Pathology; 1999 Aug; 31(3):247-51. PubMed ID: 10503271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparison of plasma matrix metalloproteases 2, 3, 9 in breast carcinomas and fibroadenomas].
    Solai F; Nardo T; Patrizi G; Annessi M; Santulli M; Amabile MI; Vasaturo F
    G Chir; 2010; 31(8-9):365-7. PubMed ID: 20843437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cathepsin-D expression in breast lesion: an immunohistochemical study.
    Brujan I; Mărgăritescu C; Simionescu C; Pirici D; Fronie A; Foarfă C; Stepan A; Vrabete M
    Rom J Morphol Embryol; 2009; 50(1):31-9. PubMed ID: 19221643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of telomerase activity in breast masses by fine-needle aspiration.
    Pearson AS; Gollahon LS; O'Neal NC; Saboorian H; Shay JW; Fahey TJ
    Ann Surg Oncol; 1998 Mar; 5(2):186-93. PubMed ID: 9527273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.